Autoimmune Diseases  >>  Toujeo (Long-acting Recombinant Human Insulin Analogue)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Toujeo (Long-acting Recombinant Human Insulin Analogue) / Sanofi
NCT01658579: Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin

Completed
2
59
US
HOE901-U300 (new formulation of insulin glargine), Lantus (insulin glargine)
Sanofi
Type 1 Diabetes Mellitus
05/13
05/13

Download Options